We Commercialize on behalf of our partners

 

Vicarius Pharma develops and executes successful European go-to-market strategies for specialty, rare/orphan and hospital products. We are launch experts with unmatched experience and have in-depth local know-how and expertise.

 

TAILORED European market entry solutions

Vicarius Pharma’s solutions overcome the risks and disadvantages of traditional European market entry strategies.

 

  • We offer highly flexible partnership models for the direct commercialization of partner assets
  • We build and manage rightsized go-to-market organizations on behalf of our partners
  • We dedicate the full attention of a ready-now, expert European Executive Team for each asset

 

PARTNERSHIP MODELS THAT PROVIDE FLEXIBILITY

When entering Europe with Vicarius Pharma, partner companies don’t lose the rights to their asset, as they would in a typical out-licensing deal. Our partnership models allow them the option to recapture the asset at any time of the partnership.

 

PARTNERSHIPS WITH INCREASED VALUE CREATION

Vicarius Pharma absorbs commercialization costs, thereby protecting partners’ P&L. Our partnership terms are based on a shared-value approach and are more attractive than typical out-licensing terms.

 

LAUNCH EXPERTS WITH UNMATCHED EXPERIENCE

We are launch experts with unmatched experience and a deep understanding of the European markets. We maximize the potential of our partners’ assets in Europe.